Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy

NCT00784212 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Photosensitive Epilepsy

Interventions

DRUG: BGG492
DRUG: BGG492
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals